𝔖 Bobbio Scriptorium
✦   LIBER   ✦

L-asparaginase treatment in acute lymphoblastic leukemia : A focus on Erwinia asparaginase

✍ Scribed by Rob Pieters; Stephen P. Hunger; Joachim Boos; Carmelo Rizzari; Lewis Silverman; Andre Baruchel; Nicola Goekbuget; Martin Schrappe; Ching-Hon Pui

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
220 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Allergic reactions to Erwinia asparagina
Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to escherichia coli asparaginase
✍ Amy Louise Billett; Stephen E. Sallan; Alexa Carls; Richard D. Gelber πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 556 KB

Background. Escherichia coli asparaginase is an active antileukemia agent in the treatment of childhood acute lymphoblastic leukemia. Allergic reactions occurred in 31 of 125 patients (24.8%) treated with weekly high-dose (25,000 IU/m2) intramuscular E. coli asparaginase and necessitated discontinua

The effect of L-asparaginase on plasma c
The effect of L-asparaginase on plasma coagulation factors in acute lymphoblastic leukemia
✍ Norma K. C. Ramsay; Peter F. Coccia; William Krivit; Mark E. Nesbit; J. Roger Ed πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 English βš– 328 KB πŸ‘ 2 views

Serial coagulation studies were performed in 26 pediatric patients with acute lymphoblastic leukemia during initial induction therapy with vincristine, prednisone, and L-asparaginase. Prolongation of screening coagulation tests was frequent: prothrombin time (in 16 of 26 patients), partial thrombopl

Methotrexate and asparaginase combinatio
Methotrexate and asparaginase combination chemotherapy in refractory acute lymphoblastic leukemia of childhood
✍ Jeffrey S. Lobel; Richard T. O'Brien; Sue McIntosh; Gregg T. Aspnes; Robert L. C πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 526 KB

Two groups of children with refractory acute lymphoblastic leukemia were treated with a regimen of methotrexate (MTX) and asparaginase (Asn'ase) based on studies of the effect of MTX in vitro on human lymphoblasts exposed to Asn'ase. Induction therapy in 12 children produced 4 complete remissions, 3